| Předmět: |
|
| Zdroj: |
Biomedical Market Newsletter; 5/16/2011, p39-40, 2p |
| Abstrakt: |
The article reports on the affiliation agreement announced by the Centre for Drug Research and Development (CDRD) and the University of Ottawa, which will obtain drug development infrastructure and expertise from CDRD. Technology Transfer and Business Enterprise (TTBE) director Joe Irvine states that the agreement with CDRD will provide research innovations in Canada. Moreover, CDRD chief executive officer (CEO) Natalie Dakers expresses gratitude in working with the university. |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
